The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell lines.

Lopes-Ventura, S

The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell lines. [electronic resource] - Journal of endocrinological investigation May 2019 - 527-540 p. digital

Publication Type: Journal Article

1720-8386

10.1007/s40618-018-0947-4 doi


Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis
Cell Cycle
Cell Proliferation
Cyclin-Dependent Kinase 4--antagonists & inhibitors
Cyclin-Dependent Kinase 6--antagonists & inhibitors
Gene Expression Regulation, Neoplastic--drug effects
Humans
Mutation
Piperazines--administration & dosage
Proto-Oncogene Proteins p21(ras)--antagonists & inhibitors
Pyridines--administration & dosage
Quinolones--administration & dosage
Thyroid Carcinoma, Anaplastic--drug therapy
Thyroid Neoplasms--drug therapy
Tumor Cells, Cultured